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Fungal cell wall polysaccharides are potent inducers of immune responses. Cohen et al. (2011) demonstrate
that innate recognition of fungal b-(1,3) glucan triggers effector functions of invariant natural killer T (iNKT)
cells through indirect, cytokine-driven activation, a process that mediates optimal protection against the
opportunistic mold Aspergillus fumigatus.Human pathogenic fungi, a small subset
of the 105 known yeasts and molds in
the fungal kingdom, have emerged as
increasingly frequent causes of infectious
morbidity and mortality, largely due to
the AIDS pandemic and advances inmed-
ical technology, such as indwelling cathe-
ters, chemotherapy, transplantation, and
targeted immunosuppression. Aspergillus
fumigatus, a saprophytic mold, causes
allergenic disease in asthmatic and cystic
fibrosis patients, and invasive disease in
immune-compromised patients, particu-
larly in thosewith leukemia and in hemato-
poietic stem-cell transplant recipients.
Humans inhale several hundred conidia
(spores) daily. Typically, this encounter is
symptomless and characterized by rapid
fungal clearance with a primary role for
neutrophils and alveolar macrophages.
In this issue of Cell Host and Microbe,
Brenner and colleagues report that natural
killer T (NKT) cell-deficientmice are defec-
tive in clearing a respiratory A. fumigatus
challenge (Cohen et al., 2011).
NKT cells are a heterogeneous pop-
ulation and part of the evolutionarily
conserved family of innate-like T lympho-
cytes. The predominant NKT cell popula-
tion recognizes lipids in the context of
the nonclassical MHC molecule CD1d.
These NKT cells typically express a T cell
receptor (TCR) composed of an invariant
a chain (with a Va14-Ja18 or a Va24-
Ja18 rearrangement in mice and humans,
respectively) paired with a limited set of
b chains. Functionally, these iNKT cells
have the capacity to release vast quan-
tities of diverse effector cytokines, in-
cluding IFN-g, IL-4, and IL-17, within
minutes of primary activation, facilitated
in part by preformed stores of cytokine
transcripts.
How iNKT cell activation is coupled to
microbial recognition has been a focusof intense interest. In bacterial, parasitic,
and viral infections, two principal modes
of iNKT cell activation have been estab-
lished (Tupin et al., 2007). Direct acti-
vation can occur when CD1d presents
microbial lipid antigen to the iNKT TCR.
Although first demonstrated for the ma-
rine sponge artificial antigen a-galacto-
sylceramide, subsequent studies have
shown that a-proteobacterial glycosphin-
golipids and galactosyldiacylglycerols
lead to iNKTcell activation.Similarly, highly
virulent bacteria, exemplified by Strepto-
coccus pneumonia, a leading cause of
pneumonia and meningitis, contain glyco-
lipid antigens (a-glucosyldiacylglycerols)
that, when presented on CD1d, stimulate
iNKT cell activation in vivo (Kinjo et al.,
2011). Direct activation is not restricted
to bacteria, as lipids from the parasite
Leishmania donovani can directly activate
iNKT cells in a CD1d-dependent, IL-12-
independent manner (Tupin et al., 2007).
Indirect iNKT activation occurs when
microbes induce innate cytokine produc-
tion in a Toll-like receptor (TLR) signaling-
dependent process and iNKT cells are in
turn activated by these cytokines. This
type of activation occurs after systemic
Salmonella typhimurium infection, typi-
cally in conjunction with CD1d-dependent
presentation of an endogenous lipid. A
recent study provides insight into how
iNKT cells can recognize both a-linked
foreign and b-linked endogenous lipids in
the context of CD1d (Pellicci et al., 2011).
How specific conditions dictate which
endogenous lipids are presented on
CD1d remains poorly understood. Viruses
use host lipids as the sole lipid source and
activate iNKT cells in an indirect manner.
Presentation of endogenous lipids by
CD1d typically plays a minor role in this
type of indirect activation (Tyznik et al.,
2008).Cell Host & Microbe 10, NThe two activationmodes are not mutu-
ally exclusive, and some pathogens have
the capacity both to synthesize exoge-
nous iNKT ligands and activate iNKT
effector functions via the indirect mode.
Recent work has begun to compare the
contribution of both modes to pathogen-
specific iNKT cell activation in vivo (Brigl
et al., 2011). Fungi could fall in this latter
category since they contain lipids that
could potentially activate iNKT cells via
CD1d. However, Brenner and colleagues
tested Aspergillus lipid extracts for iNKT
stimulatory activity and found none.
Instead, the stimulatory activity resided
in the heat-, acid-, and base-resistant
fraction that is highly enriched in b-glucan
polymers. Furthermore, dendritic cells
(DCs) deficient in dectin-1, a C-type lectin
receptor that binds b-(1,3) glucans (Drum-
mond and Brown, 2011), showed defec-
tive iNKT cell activation following stimu-
lation with A. fumigatus as well as a
range of other clinically important fun-
gal pathogens (Candida albicans, Histo-
plasma capsulatum, and Alternaria alter-
nata). Although dectin-1 can mediate
iNKT cell activation following fungal expo-
sure, redundant activation mechanisms
(via Toll-like and other C-type lectin re-
ceptors) ensure that iNKT cell activation
occurs even with fungal pathogens (e.g.,
Cryptococcus neoformans) that do not
expose dectin-1 ligands on their cell sur-
face (Kawakami et al., 2001).
b-(1,3) glucans confer rigidity and
strength to the fungal cell wall and are
conserved across many different fungi.
Obligate b-glucan exposure occurs dur-
ing growth (Figure 1), for example as
A. fumigatus conidia undergo swelling,
the first step in germination into filamen-
tous hyphae, or as C. albicans divides,
resulting in bud and birth scars. From
a fungal perspective, tight regulation ofovember 17, 2011 ª2011 Elsevier Inc. 421
Figure 1. Model of Fungal iNKT Activation
In (1), fungi expose cell wall b-(1,3) glucan following morphological transitions (e.g., conidial swelling
[Aspergillus fumigatus]), cell division (e.g., bud or birth scars [Candida albicans]), or disruption of the
external a-glucan layer (Histoplasma capsulatum). In (2), b-(1,3) glucan ligation at the cell surface or within
phagosomes induces dectin-1 signaling, which, in concert with collaborative Toll-like receptor signaling,
leads to DC activation. In (3), DC-derived IL-12 is a key element for iNKT activation together with CD1d-
dependent TCR interactions, although A. fumigatus-derived lipids do not appear to contribute to iNKT
activation, consistent with a role for endogenous lipid antigen (shown in yellow) presentation to the
iNKT TCR. In (4), rapid release of effector cytokines such as IFN-g by iNKT cells follows activation. How
iNKT activation mediates enhanced fungal clearance in vivo remains an important unresolved question.
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Previewsb-glucan exposure likely confers survival
benefits in natural environments, while
mammalian b-glucan detection acts as
a fungal growth indicator, inducing tar-
geted responses that include iNKT cell
activation.
Although Cohen et al. do not find a
role for A. fumigatus lipids in direct iNKT
activation, dendritic cell CD1d expression
remains essential. This suggests that
CD1d presents endogenous lipids during
fungus-induced iNKT cell activation. It is
unclear if b-(1,3) glucan recognition im-
pacts the nature and agonist properties
of endogenous lipids during this process.
A recent study by Brennan et al. provides
evidence for such a lipid repertoire shift in
DCs following TLR stimulation, resulting in
the CD1d-dependent presentation of an
endogenous lipid with potent agonist
properties (b-D-glucopyranosylceramide)
(Brennan et al., 2011).
Cohen et al. show that IL-12 is dispens-
able for iNKT cell airway accumulation
during respiratory fungal infection, but
essential for IFN-g production. The role
of other cytokines and chemokines in422 Cell Host & Microbe 10, November 17, 20this process remains poorly under-
stood, but a previous study implicates
MCP-1/CCL2 in iNKT cell accumulation
in a respiratory cryptococcal infection
model (Kawakami et al., 2001), and fur-
ther experiments are required to dis-
sect the molecular cues that mediate
iNKT recruitment and activation. The
lung-cell population that activates iNKTs
in situ has not been identified; both alve-
olar macrophages and lung monocyte-
derived CD11b+ dendritic cells take up
A. fumigatus spores in vivo (Hohl et al.,
2009). Finally, how iNKT cell activation is
coupled to rapid fungal clearance remains
unclear as well (Figure 1), but does not
appear to involve iNKT IL-17 production.
It will be interesting to see whether other
innate-like T lymphocytes such as the
recently characterized mucosal-associ-
ated invariant T cells (MAITs) respond to
fungal infections in a similar fashion.
How iNKT cells contribute to the patho-
genesis of fungus-induced allergenic or
invasive disease states represents an
important area of future research. In
patients with invasive aspergillosis (IA),11 ª2011 Elsevier Inc.loss of neutrophil number or function
represents a significant clinical risk that
may be diminished by auxiliary host
defenses. For example, NK cells confer
protective benefits in murine models of
neutropenic aspergillosis (Park et al.,
2009). Whether iNKT cells can enhance
fungal clearance in the context of host
immune damage remains undefined.
Exploring the population dynamics and
mechanisms of iNKT activity during fungal
disease states is likely to inform new
opportunities for therapeutic intervention.
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